The mTOR pathway functions primarily through the PI3K/AKT pathway to activate the tumour cells; members of the PI3K pathway family are frequently altered in human cancers, which leads to cell survival and proliferation, metastasis and activation of some secretion functions[2, 63]. This evidence concerns the gene AKT1 and cancer.